FDAnews Device Daily Bulletin
Medical Devices / Submissions and Approvals

Prescient Surgical Achieves FDA De Novo Clearance for CleanCision System

Jan. 25, 2017
A A

FDA’s CDRH has granted de novo clearance to Prescient Surgical’s CleanCision wound retraction and protection system.

The device is designed for surgical wound edge protection, retraction, and continuous cleansing with a sterile irrigant solution.

Prescient plans to launch the CleanCision device in 2017. — Cynthia Jessup

View today's stories